Tilletiopsis minor: a new etiologic agent of human subcutaneous mycosis in an immunocompromised host.
We describe herein the isolation of Tilletiopsis minor from a subcutaneous cyst of a 70-year-old immunocompromised male. The diagnosis was based on repeated isolation of the fungus, observation of hyphal elements in tissue sections, the ability of the mold to grow at or near body temperature, and the achievement of a complete cure following surgery and antifungal therapy.
Ramani
R
R
Laboratories for Mycology, Wadsworth Center, New York State Department of Health, Albany 12208-2002, USA.
Kahn
B T
BT
Chaturvedi
V
V
D000368:Aged; D000743:Anemia, Hemolytic / Q000601:surgery; D000935:Antifungal Agents / Q000627:therapeutic use*; D003560:Cysts / Q000382:microbiology / Q000473:pathology / Q000628:therapy; D003646:Debridement; D003881:Dermatomycoses / Q000382:microbiology* / Q000473:pathology / Q000628:therapy; D006801:Humans; D016867:Immunocompromised Host; D008297:Male; D003904:Mitosporic Fungi / Q000145:classification / Q000254:growth & development / Q000302:isolation & purification*; D013156:Splenectomy; D013172:Spores, Fungal
D000935:Antifungal Agents